All images are actor portrayals
Welcome To CoverOne
CoverOne® provides patient access and reimbursement support services to help eligible patients gain appropriate access to BAVENCIO® (avelumab) and TEPMETKO® (tepotinib) in the United States. We recognize that each patient’s situation is different and are dedicated to helping BAVENCIO and TEPMETKO patients one at a time.
For BAVENCIO Patients, please contact us:
Phone: 844-8COVER1 (844-826-8371)
Fax: 800-214-7295
Hours: Monday-Friday 8:00am-5:00pm Eastern Time
For TEPMETKO Patients, please contact us:
Phone: 844-662-3631
Fax: 844-501-0062
Hours: Monday-Friday 8:00am-8:00pm Eastern Time
To request services for BAVENCIO or TEPMETKO, please complete and fax the appropriate CoverOne Enrollment Form. For BAVENCIO, you may also enroll online through our BAVENCIO CoverOne Enrollment Portal.
©2024 Merck KGaA, Darmstadt, Germany or its affiliates. All rights reserved. EMD Serono is the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada. BAVENCIO, TEPMETKO and CoverOne are registered trademarks of Merck KGaA, Darmstadt, Germany or its affiliates.
US-MULO-00096 06/24
©2024 Merck KGaA, Darmstadt, Germany or its affiliates. All rights reserved. EMD Serono is the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada. BAVENCIO, TEPMETKO and CoverOne are registered trademarks of Merck KGaA, Darmstadt, Germany or its affiliates.
US-MULO-00096 06/24
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch, or call 1-800-FDA-1088. The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient. The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.